{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:30:28Z","timestamp":1793457028064,"version":"4.5.0"},"reference-count":44,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Neurol Disord"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec><jats:title>Objective:<\/jats:title><jats:p> To report on safety and effectiveness of subcutaneous cladribine (Litak<jats:sup>\u00ae<\/jats:sup>) in multiple sclerosis (MS) patients. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p> Litak<jats:sup>\u00ae<\/jats:sup> was offered to MS-patients irrespective of disease course. Litak<jats:sup>\u00ae<\/jats:sup> 10 mg was administered for 3\u20134 days during week 1. Based on lymphocyte count at week 4, patients received another 0\u20133 doses at week 5. A second course was administered 11 months later. Follow-up included adverse events, relapses, expanded disability status scale (EDSS), 9-hole-peg and Timed-25-foot-walking tests, no-evidence-of-disease-activity (NEDA), no-evidence-of-progression-or-active-disease (NEPAD), MRI, cerebrospinal fluid (CSF) neurofilament light chain (NfL), and lymphocyte counts. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p> In all, 208 patients received at least one course of treatment. Age at baseline was 44 (17\u201372) years and EDSS 0\u20138.5. Cladribine was generally well tolerated. One myocardial infarction, one breast cancer, and three severe skin reactions occurred without long-term sequelae. Two patients died (one pneumonia, one encephalitis). Lymphopenia grade 3 occurred in 5% and grade 4 in 0.5%. In 94 out of 116 pwMS with baseline and follow-up (BaFU) data after two treatment courses, EDSS remained stable or improved. At 18 months, 64% of patients with relapsing MS and BaFU data ( n\u2009=\u200939) had NEDA. At 19 months, 62% of patients with progressive MS and BaFU data ( n\u2009=\u200913) had NEPAD. Of n\u2009=\u200913 patients whose CSF-NfL at baseline was elevated, 77% were normalised within 12 months. <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p> Litak<jats:sup>\u00ae<\/jats:sup> was well tolerated. Effectiveness in relapsing MS appeared similar to cladribine tablets and was encouraging in progressive MS. Our data suggest cladribine may be safe and effective in MS-patients irrespective of their disease stage. <\/jats:p><\/jats:sec>","DOI":"10.1177\/17562864211057661","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T08:14:11Z","timestamp":1637914451000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":11,"title":["Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients"],"prefix":"10.1177","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1207-8625","authenticated-orcid":false,"given":"Kimberley","family":"Allen-Philbey","sequence":"first","affiliation":[{"name":"Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK"},{"name":"Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"De Trane","sequence":"additional","affiliation":[{"name":"Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Mao","sequence":"additional","affiliation":[{"name":"Kingmed College of Laboratory Medicine, Guangzhou Medical University, Guangzhou, China"},{"name":"Department of Clinical Medicine, Medical School, Xiangnan University, Chenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"\u00c1lvarez-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, Basel, Switzerland"},{"name":"Research Center for Clinical Neuroimmunology and Neuroscience, University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joela","family":"Mathews","sequence":"additional","affiliation":[{"name":"Pharmacy Department, The Royal London Hospital, Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"MacDougall","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Stennett","sequence":"additional","affiliation":[{"name":"Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK"},{"name":"Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhou","sequence":"additional","affiliation":[{"name":"Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Yildiz","sequence":"additional","affiliation":[{"name":"Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK"},{"name":"Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Adams","sequence":"additional","affiliation":[{"name":"Neuroradiology Department, The Royal London Hospital, Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Blain","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Chapman","sequence":"additional","affiliation":[{"name":"Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Chung","sequence":"additional","affiliation":[{"name":"The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cris S","family":"Constantinescu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nottingham University Hospitals NHS Trust, Nottingham, UK"},{"name":"Mental Health and Clinical Neuroscience Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Dalton","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A","family":"Farrell","sequence":"additional","affiliation":[{"name":"The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK"},{"name":"Department of Neuroinflammation, National Hospital for Neurology and Neurosurgery, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonora","family":"Fisniku","sequence":"additional","affiliation":[{"name":"Brighton and Sussex University Hospitals NHS Trust, Brighton, UK; Brighton and Sussex Medical School, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Ford","sequence":"additional","affiliation":[{"name":"Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Gran","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nottingham University Hospitals NHS Trust, Nottingham, UK"},{"name":"Mental Health and Clinical Neuroscience Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hobart","sequence":"additional","affiliation":[{"name":"Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaleh","family":"Khaleeli","sequence":"additional","affiliation":[{"name":"Department of Neuroinflammation, National Hospital for Neurology and Neurosurgery, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Mattoscio","sequence":"additional","affiliation":[{"name":"Queen\u2019s Hospital, Barking Havering and Redbridge Hospital NHS Trust, Romford, UK; Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Pavitt","sequence":"additional","affiliation":[{"name":"Dental Translational and Clinical Research Unit, School of Dentistry, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Pearson","sequence":"additional","affiliation":[{"name":"Department of Neurology, Swansea Bay University Health Board, Port Talbot, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Peruzzotti-Jametti","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences and National Institute for Health Research (NIHR) Biomedical Research Centre, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Scalfari","sequence":"additional","affiliation":[{"name":"Centre of Neuroscience, Department of Medicine Charing Cross Hospital, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil","family":"Sharrack","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"},{"name":"Department of Neuroscience and NIHR Neurosciences Biomedical Research Centre, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Silber","sequence":"additional","affiliation":[{"name":"Department of Neurology, King\u2019s College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma C","family":"Tallantyre","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Wales, Cardiff, UK"},{"name":"Division of Psychological Medicine and Clinical Neuroscience, School of Medicine, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"Webb","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience, Department of Neurology, Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin P","family":"Turner","sequence":"additional","affiliation":[{"name":"Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK"},{"name":"Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Marta","sequence":"additional","affiliation":[{"name":"Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK"},{"name":"Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmilee","family":"Gnanapavan","sequence":"additional","affiliation":[{"name":"Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK"},{"name":"Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Juliusson","sequence":"additional","affiliation":[{"name":"Department of Hematology, Sk\u00e5ne University Hospital, Lund, Sweden"},{"name":"Stem Cell Centre, Department of Laboratory Medicine, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9995-1700","authenticated-orcid":false,"given":"Gavin","family":"Giovannoni","sequence":"additional","affiliation":[{"name":"Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK"},{"name":"Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Baker","sequence":"additional","affiliation":[{"name":"Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9293-8893","authenticated-orcid":false,"given":"Klaus","family":"Schmierer","sequence":"additional","affiliation":[{"name":"Neuroscience, Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust, London, UK Neuroscience, Surgery and Trauma, The Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"key":"bibr1-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520970841"},{"key":"bibr2-17562864211057661","unstructured":"Gandey A. FDA rejects oral cladribine for multiple sclerosis. Medscape 2011, https:\/\/www.medscape.com\/viewarticle\/738239 (accessed 24 May 2021)."},{"key":"bibr3-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2017.01.042"},{"key":"bibr4-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-8830-y"},{"key":"bibr5-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000360"},{"key":"bibr6-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000158"},{"key":"bibr7-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517726380"},{"key":"bibr8-17562864211057661","unstructured":"England NHS. NHS England \u00bb NHS England strikes new deals to make two new innovative treatments available routinely on the NHS, https:\/\/www.england.nhs.uk\/2017\/11\/nhs-england-strikes-new-deals-to-make-two-new-innovative-treatments-available-routinely-on-the-nhs\/ (accessed 21 March 2021)."},{"key":"bibr9-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.11.001"},{"key":"bibr10-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.10.1514"},{"key":"bibr11-17562864211057661","unstructured":"BartsMS. Cladribine information pack, https:\/\/www.slideshare.net\/KlausSchmierer\/bartsms-infosafetyconsentpackjuly-2018 (accessed 9 December 2020)."},{"key":"bibr12-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.05.010"},{"key":"bibr13-17562864211057661","unstructured":"Litak \u2013 Summary of product characteristics, https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/litak-epar-product-information_en.pdf"},{"key":"bibr14-17562864211057661","first-page":"1","volume":"4","author":"Mao Z","year":"2018","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"bibr15-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.11.1444"},{"key":"bibr16-17562864211057661","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00464"},{"key":"bibr17-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2009.09.014"},{"key":"bibr18-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000880"},{"key":"bibr19-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517690824"},{"key":"bibr20-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.410"},{"key":"bibr21-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102140"},{"key":"bibr22-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2020.100279"},{"key":"bibr23-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0902533"},{"key":"bibr24-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30069-3"},{"key":"bibr25-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01314-8"},{"key":"bibr26-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010284"},{"key":"bibr27-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.64.3.402"},{"key":"bibr28-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000937"},{"key":"bibr29-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1818-y"},{"key":"bibr30-17562864211057661","unstructured":"Multiple Sclerosis Top 10, https:\/\/www.jla.nihr.ac.uk\/priority-setting-partnerships\/multiple-sclerosis\/top-10-priorities\/ (accessed 14 July 2021)."},{"key":"bibr31-17562864211057661","unstructured":"Understand, prevent and reverse progression 2020, https:\/\/www.progressivemsalliance.org\/what-we-do\/accelerate-treatments\/ (accessed 14 July 2021)."},{"key":"bibr32-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000990"},{"key":"bibr33-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.3065"},{"key":"bibr34-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.3977"},{"key":"bibr35-17562864211057661","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.96.15_supplement.2235","volume":"96","author":"Wiendl H","year":"2021","journal-title":"Neurology"},{"key":"bibr36-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51206"},{"key":"bibr37-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520921087"},{"key":"bibr38-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70023-0"},{"key":"bibr39-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102945"},{"key":"bibr40-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.5.1145"},{"key":"bibr41-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20180926"},{"key":"bibr42-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103190"},{"key":"bibr43-17562864211057661","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-7004-1"},{"key":"bibr44-17562864211057661","unstructured":"Lieberman D, Mangat H, Allen-Philbey K, et al Cladribine to halt deterioration in people with advanced multiple sclerosis (ChariotMS) [Poster] September 11\u201313 2020, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04695080"}],"container-title":["Therapeutic Advances in Neurological Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864211057661","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562864211057661","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864211057661","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T17:33:22Z","timestamp":1740764002000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562864211057661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":44,"alternative-id":["10.1177\/17562864211057661"],"URL":"https:\/\/doi.org\/10.1177\/17562864211057661","relation":{},"ISSN":["1756-2864","1756-2864"],"issn-type":[{"value":"1756-2864","type":"print"},{"value":"1756-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"article-number":"17562864211057661"}}